METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer

CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first-line treatment for advanced NSCLC

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer

Sym015 shows superior specificity compared to TKIs for NSCLC

Brigatinib for NSCLC, latest research and overcoming complications

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer

Do immune checkpoint inhibitors work in EGFR mutant lung cancer?

COVID-19: Risk of millions relapsing back to smoking

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19

COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic

Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19